Collaboration for Cancer Outcomes, Research and Evaluation (CCORE), Ingham Institute for Applied Medical Research, UNSW Sydney, Liverpool, NSW, Australia; Liverpool and Macarthur Cancer Therapy Centres, Liverpool, NSW, Australia; School of Medicine, Western Sydney University, Campbelltown, NSW, Australia; Cancer Research Division, Cancer Council NSW, Kings Cross, NSW, Australia; Sydney Medical School - Public Health, University of Sydney, Sydney, NSW, Australia.
Cancer Research Division, Cancer Council NSW, Kings Cross, NSW, Australia; Sydney Medical School - Public Health, University of Sydney, Sydney, NSW, Australia; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
Clin Oncol (R Coll Radiol). 2020 May;32(5):282-291. doi: 10.1016/j.clon.2020.01.007. Epub 2020 Jan 30.
Actual radiotherapy utilisation rates tend to be lower than the estimated optimal rates. Little is known about the factors contributing to this difference. Our aim was to identify factors associated with radiotherapy receipt for a cohort of cancer patients in New South Wales (NSW), Australia.
In total, 267 153 participants in the NSW 45 and Up Study completed a questionnaire during 2006-2009 providing detailed health and socio-demographic information and consented to record linkage with administrative health datasets. Single primary cancers diagnosed after study enrolment were identified through linkage with the NSW Cancer Registry to December 2013. Radiotherapy receipt was determined from claims to the Medicare Benefits Schedule and/or records in the NSW Admitted Patient Data Collection (2006 to June 2016). Competing risks regression was used to examine associations between health and socio-demographic characteristics and radiotherapy treatment.
Of 17 873 patients with an incident cancer, 5414 (30.3%) received radiotherapy during follow-up (median 5.3 years). Patients less likely to receive radiotherapy were aged <60 or 80+ years, female, had a Charlson co-morbidity index of 1+, needed help with daily tasks or lived ≥100 km from the nearest radiotherapy centre.
Distinct subgroups of patients are less likely to receive radiotherapy. Advocacy and/or policy changes are needed to improve access.
实际放射治疗的使用率往往低于估计的最佳使用率。对于导致这种差异的因素知之甚少。我们的目的是确定澳大利亚新南威尔士州(NSW)一组癌症患者接受放射治疗的相关因素。
共有 267153 名参加 NSW 45 岁及以上研究的参与者在 2006-2009 年期间完成了一份问卷,提供了详细的健康和社会人口统计学信息,并同意将其记录与行政健康数据集进行链接。通过与新南威尔士癌症登记处的链接,在研究登记后诊断出单一原发性癌症,截至 2013 年 12 月。通过向 Medicare 福利计划提出索赔和/或在新南威尔士州住院病人数据收集(2006 年至 2016 年 6 月)记录来确定放射治疗的使用情况。使用竞争风险回归来检查健康和社会人口统计学特征与放射治疗之间的关联。
在 17873 名患有癌症的患者中,5414 名(30.3%)在随访期间接受了放射治疗(中位数为 5.3 年)。不太可能接受放射治疗的患者年龄<60 岁或≥80 岁,女性,Charlson 合并症指数为 1+,需要日常帮助或距离最近的放射治疗中心≥100 公里。
不同的患者亚组不太可能接受放射治疗。需要进行宣传和/或政策改革以改善获得途径。